This program is of particular interest to drug development professionals in pharma and biotech companies. It is also relevant for (junior) physicians at academic or private clinical centers involved in the clinical development of new cancer therapies. They will benefit from participating in parts A and B combined or part B only, depending on their starting oncology knowledge.

Part A provides basic education on cancer biology, diagnosis and treatment and is therefore of interest to anyone looking to acquire general oncology knowledge. 

Parts A (day 1) and B (days 2 and 3) may be booked separately or combined. For successful participation in either part, an understanding of the basic principles of biology and medicine at the graduate level is recommended. 

Website: https://go.evvnt.com/641483-0?pid=4319

Time: 09:00 to 17:00